comparemela.com

Latest Breaking News On - Mikhail kosiborod - Page 7 : comparemela.com

Semaglutide Beneficial in Obese Patients With HFpEF

The GLP1-RA semaglutide may help obese patients who have heart failure with preserved ejection fraction (HFpEF) improve their quality of life.

United statesMikhail kosiborodSaint luke mid america heart instituteEuropean society of cardiology congressNovo nordiskEuropean societyCardiology congressNew england journalSaint lukeMid america heart instituteKansas cityClinical summary scoreKansas city cardiomyopathy questionnaire

Weight-loss drugs Ozempic and Wegovy also protect your heart

Semaglutide reduces heart failure symptoms by bringing down body weight.

Carsten snejbjerg bloomberg gettyNovo nordiskMikhail kosiborodSaint luke mid america heart instituteNew england journalSaint lukeMid america heart instituteKansas city

Our Goal Is Not to Blame : What We Heard This Week

Quotable quotes heard by <em>MedPage Today</em>'s reporters

France generalNew zealandBoston universityUnited statesNew yorkErik sveberg dietrichsChristopher wallisMikhail kosiborodBob wachterMathieu kerneisJennifer craigAnn mckeeAlison leeReshma jagsiPitie salpetriere university hospitalUniversity of california san francisco

SGLT2 Inhibitors Not Associated With Improved Survival in Patients Hospitalized With COVID-19

In a previous trial, DARE-19, investigators reported that the SGLT2 inhibitor dapagliflozin did not benefit patients with COVID-19 who had cardiometabolic risk factors.

Mikhail kosiborodSaint luke mid america heart instituteWorld health organization rapid evidence appraisalTherapies working groupWorking groupSaint lukeMid america heart institute

Big Win for Anti-Obesity Medication in Heart Failure

Semaglutide led to meaningful reductions in symptoms, weight in patients with obesity and HFpEF

United statesYale new haven hospitalHarlan krumholzMikhail kosiborodHaroldh hines jrEmily huttoYale school of medicineInstitute forOutcomes researchPublic healthEuropean society of cardiologyEuropean society of cardiology congressYale schoolEuropean societyCardiology congressNew england journal

vimarsana © 2020. All Rights Reserved.